These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2017608)

  • 21. Influence of menstrual cycle variations on natural killer cytotoxicity and antibody-dependent cellular cytotoxicity to cells infected with herpes simplex virus.
    Gonik B; Loo LS; Bigelow R; Kohl S
    J Reprod Med; 1985 Jun; 30(6):493-6. PubMed ID: 4020792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human colostral cytotoxicity: I. Antibody-dependent cellular cytotoxicity against Herpes simplex viral-infected cells mediated by colostral cells.
    Kohl S; Malloy MM; Pickering LK; Morriss FH; Adcock EW; Walters DL
    J Clin Lab Immunol; 1978 Nov; 1(3):221-4. PubMed ID: 756470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-dependent cellular cytotoxicity against cells infected with herpes simplex virus type 1 in Igh-1 disparate congenic mice.
    Tamesis RR; Rodriguez A; Hoang-Xuan T; Foster CS
    Ger J Ophthalmol; 1993 Aug; 2(4-5):218-23. PubMed ID: 8220102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-glycoprotein g antibodies of herpes simplex virus 2 contribute to complete protection after vaccination in mice and induce antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
    Görander S; Ekblad M; Bergström T; Liljeqvist JÅ
    Viruses; 2014 Nov; 6(11):4358-72. PubMed ID: 25398047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural killer cytotoxicity and antibody-dependent cell cytotoxicity to herpes simplex virus-infected target cells in murine pregnancy.
    Loftin KC; Gonik B; Kumaran P
    Am J Reprod Immunol Microbiol; 1988 Jun; 17(2):53-6. PubMed ID: 2847568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji.
    Fitzgerald-Bocarsly P; Feldman M; Curl S; Schnell J; Denny T
    J Immunol; 1989 Aug; 143(4):1318-26. PubMed ID: 2526183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody-dependent cellular cytotoxicity in HIV infections.
    Ahmad A; Menezes J
    FASEB J; 1996 Feb; 10(2):258-66. PubMed ID: 8641559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural killer cell cytotoxicity and antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells in human pregnancy.
    Gonik B; Loo LS; West S; Kohl S
    Am J Reprod Immunol Microbiol; 1987 Jan; 13(1):23-6. PubMed ID: 3032009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis in human neonates of defective antibody-dependent cellular cytotoxicity and natural killer cytotoxicity to herpes simplex virus-infected cells.
    Kohl S; Loo LS; Gonik B
    J Infect Dis; 1984 Jul; 150(1):14-9. PubMed ID: 6086768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epitopes of herpes simplex virus type 1 glycoprotein B that bind type-common neutralizing antibodies elicit type-specific antibody-dependent cellular cytotoxicity.
    Sanchez-Pescador L; Paz P; Navarro D; Pereira L; Kohl S
    J Infect Dis; 1992 Sep; 166(3):623-7. PubMed ID: 1380051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.
    Sung AP; Tang JJ; Guglielmo MJ; Redelman D; Smith-Gagen J; Bateman L; Hudig D
    J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of storage of blood on mononuclear cell antibody-dependent cellular cytotoxicity to herpes simplex virus-infected cells.
    Castillo de Febres O; Kohl S
    Clin Immunol Immunopathol; 1983 Aug; 28(2):185-91. PubMed ID: 6872360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies.
    Cheng ZJ; Garvin D; Paguio A; Moravec R; Engel L; Fan F; Surowy T
    J Immunol Methods; 2014 Dec; 414():69-81. PubMed ID: 25086226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
    Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
    MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective production of anti-herpes simplex virus antibody by neonatal mice. Reconstitution with Ia+ macrophages and T helper lymphocytes from nonimmune adult syngeneic mice.
    Kohl S; Thomas JW; Loo LS
    J Immunol; 1986 Apr; 136(8):3038-44. PubMed ID: 3007609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibodies to epitopes of herpes simplex virus type 1 glycoprotein B (gB) in human sera: analysis of functional gB epitopes defined by inhibition of murine monoclonal antibodies.
    Sanchez-Pescador L; Pereira L; Charlebois ED; Kohl S
    J Infect Dis; 1993 Oct; 168(4):844-53. PubMed ID: 7690824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of neonatal mice against herpes simplex viral infection by human antibody and leukocytes from adult, but not neonatal humans.
    Kohl S; Loo LS; Pickering LK
    J Immunol; 1981 Oct; 127(4):1273-5. PubMed ID: 7276559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-2 protects neonatal mice from lethal herpes simplex virus infection: a macrophage-mediated, gamma interferon-induced mechanism.
    Kohl S; Loo LS; Drath DB; Cox P
    J Infect Dis; 1989 Feb; 159(2):239-47. PubMed ID: 2492588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies - impact of effector cells.
    Chung S; Lin YL; Reed C; Ng C; Cheng ZJ; Malavasi F; Yang J; Quarmby V; Song A
    J Immunol Methods; 2014 May; 407():63-75. PubMed ID: 24704820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of antibody-mediated protection against herpes simplex virus infection in athymic nude mice: requirement of Fc portion of antibody.
    Hayashida I; Nagafuchi S; Hayashi Y; Kino Y; Mori R; Oda H; Ohtomo N; Tashiro A
    Microbiol Immunol; 1982; 26(6):497-509. PubMed ID: 6290850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.